Skip to main content
. 2013 Dec 11;8(12):e83018. doi: 10.1371/journal.pone.0083018

Table 1. Characteristics of AML samples.

Patient n° Age Diagnosis FAB Cyto Phenotype
P_1 67 APL M3 t(15;17) DR-, CD34-, CD13+, CD33+, CD117+, CD45RA+, CD45RO-
P_2 AML
P_3 AML 46, XX CD13+, CD33+, CD24+, CD11c, CD16+/-
P_4 30 AML M2 (gate ≈45%) CD34+, CD13+, HLA-, DR+, CD19+, CD45RA+, CD71+, CD117+, MPO+
P_5 58 AML M2 CD33+, CD13-, CD11c+, CD11b+/-, CD117+/-, CD34+/-, DR+, MPO-
P_6 63 AML M1 CD13+/-, CD33+, CD117+/-, CD14+/-, CD34+/-, CD45+/-